POKONZA (POTASSIUM CHLORIDE)
POKONZA (POTASSIUM CHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: POKONZA; Generic name: POTASSIUM CHLORIDE; Manufacturer: Carwin Pharmaceutical Associates, LLC.
| Brand name | POKONZA |
|---|---|
| Generic name | POTASSIUM CHLORIDE |
| Manufacturer | Carwin Pharmaceutical Associates, LLC |
| Used for | 1 INDICATIONS AND USAGE POKONZA ® (Potasium Chloride for Oral Solution, USP) is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. POKONZA ® (Potassium Chloride for Oral Solution, USP) is a potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassiumrich foods or diuretic dose reduction is insufficient. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Dilute prior to administration. ( 2.1 , 5.1 ) Monitor serum potassium and adjust dosage accordingly ( 2.2 , 2.3 ) If serum potassium concentration is <2.5 mEq/L, use intravenous potassium instead of oral supplementation ( 2.1 ) Treatment of hypokalemia: Adults: Initial doses range from 40-100 mEq/day in 2-5 divided doses: limit doses to 40 mEq per dose. Total daily dose should not exceed 200 mEq ( 2.2 ) Pediatric patients aged birth to 16 years old: 2-4 mEq/kg/day in |
| Active ingredient(s) | POTASSIUM CHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0700c19e-abca-4527-8944-e4440a32e3af |